Recombinant human platelet-activating factor acetylhydrolase for treatment of severe sepsis: Results of a phase II, multicenter, randomized, double-blind, placebo-controlled, clinical trial. - Opal,S.; Laterre,P.F.; Abraham,E.; Francois,B.; Wittebole,X.; Lowry,S.; Dhainaut,J.F.; Warren,B.; Dugernier,T.; Lopez,A.; Sanchez,M.; Demeyer,I.; et al. (Crit Care Med, 2004)